GC Pharma

Search
Keyword Search
Plasma Derivatives Office Vaccines Subsidiary Pipeline R&D Media Stock Company Recruit
Product Search
close
Total Menu KOR
close

What we are working on

R&DR&D Story

We specialize in the development of essential
but difficult-to-make drugs.

VIEW MORE

R&DPipeline

We strive to develop new
and innovative products.

VIEW MORE

R&DPartnership

To strengthen our pipeline and
our understanding of disease.

VIEW MORE

  • PRODUCTS I.V.-Globulin SN i...

    I.V.-Globulin SN inj.

    Including high purity IgG 
immune function improved
formulation
     VIEW MORE

  • PRODUCTS Albumin inj.-GCC

    Albumin inj.-GCC

    Yellow to yellowish transparent 
liquid formulation
& Human albumin solution
     VIEW MORE

  • PRODUCTS Green-VIII inj

    Green-VIII inj

    Human coagulation factor VIII
     VIEW MORE

Who we are?

Stock Info

Share price
at 9:30 PM, UTC

Our business

  • NO.1 
    in plasma & flu vaccine
market (S.Korea)
  • 50 
    We are exporting our 
products to more than 
50 countries
  • TOP 
    Vaccine producer of 
PAHO market
About Us
We possess 17 pharmaceutical and
healthcare affiliated companies. VIEW MORE

What's happening

Newsroom

Green Cross Introduces Its New Master Brand “GC”

2 Jan, 2018

R&D Highlights

Green Cross’ Tetanus-Diphtheria (Td) Vacci... 
								
									Immunization against tetanus and diphtheria is required by law under the National Immunization Program (...
50th banner